(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1320241 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of DLL4 mRNA CTD PMID:22079256 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of DLL4 mRNA CTD PMID:27840820 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1320242 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of DLL4 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to DLL4 promoter] CTD PMID:19654925 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DLL4 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DLL4 mRNA CTD PMID:34747641 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1320241 6480464 tetrabromobisphenol A results in increased expression of DLL4 mRNA CTD PMID:33476716 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1320242 6480464 tetrabromobisphenol A results in increased expression of DLL4 mRNA CTD PMID:35230478 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of DLL4 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol increases expression ISO RGD:1320241 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DLL4 mRNA CTD PMID:33476716 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1320242 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of DLL4 exon CTD PMID:33297965 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of DLL4 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1320241 6480464 Acrylamide results in increased expression of DLL4 mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO RGD:1320241 6480464 Aflatoxin B1 results in decreased methylation of DLL4 3' UTR CTD PMID:30157460 aristolochic acid A increases expression ISO RGD:1320241 6480464 aristolochic acid I results in increased expression of DLL4 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1320242 6480464 arginyl-2, '6'-dimethyltyrosyl-lysyl-phenylalaninamide inhibits the reaction [[Arsenic results in increased expression of NOTCH1 protein] which results in increased expression of DLL4 protein] CTD PMID:32647881 arsane increases expression ISO RGD:1320242 6480464 [Arsenic results in increased expression of NOTCH1 protein] which results in increased expression of DLL4 protein CTD PMID:32647881 arsenic atom multiple interactions ISO RGD:1320242 6480464 arginyl-2, '6'-dimethyltyrosyl-lysyl-phenylalaninamide inhibits the reaction [[Arsenic results in increased expression of NOTCH1 protein] which results in increased expression of DLL4 protein] CTD PMID:32647881 arsenic atom increases expression ISO RGD:1320242 6480464 [Arsenic results in increased expression of NOTCH1 protein] which results in increased expression of DLL4 protein CTD PMID:32647881 arsenite(3-) increases methylation ISO RGD:1320241 6480464 arsenite results in increased methylation of DLL4 promoter CTD PMID:23974009 arsenous acid decreases expression ISO RGD:1320241 6480464 Arsenic Trioxide results in decreased expression of DLL4 CTD PMID:25088040 benzo[a]pyrene decreases expression ISO RGD:1320242 6480464 Benzo(a)pyrene results in decreased expression of DLL4 mRNA CTD PMID:21569818 , PMID:27195522 benzo[a]pyrene affects methylation ISO RGD:1320241 6480464 Benzo(a)pyrene affects the methylation of DLL4 3' UTR CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:1320242 6480464 Benzo(a)pyrene results in increased expression of DLL4 mRNA CTD PMID:22610609 , PMID:32417428 benzo[e]pyrene increases methylation ISO RGD:1320241 6480464 benzo(e)pyrene results in increased methylation of DLL4 3' UTR CTD PMID:30157460 bisphenol A increases expression ISO RGD:1320241 6480464 bisphenol A results in increased expression of DLL4 mRNA CTD PMID:33476716 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DLL4 mRNA, bisphenol A results in increased expression of DLL4 protein CTD PMID:29438945 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of DLL4 gene CTD PMID:28505145 bisphenol A decreases methylation ISO RGD:1320242 6480464 bisphenol A results in decreased methylation of DLL4 promoter CTD PMID:27312807 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DLL4 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol F increases expression ISO RGD:1320241 6480464 bisphenol F results in increased expression of DLL4 mRNA CTD PMID:33476716 bleomycin A2 multiple interactions ISO RGD:1320242 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of DLL4 protein], lenabasum promotes the reaction [Bleomycin results in decreased expression of DLL4 protein] CTD PMID:30825431 bleomycin A2 decreases expression ISO RGD:1320242 6480464 Bleomycin results in decreased expression of DLL4 protein CTD PMID:30825431 BQ 123 multiple interactions ISO RGD:1320242 6480464 cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Oxygen results in increased expression of DLL4 mRNA] CTD PMID:25203536 cadmium atom multiple interactions ISO RGD:1320241 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DLL4 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1320241 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DLL4 mRNA CTD PMID:35301059 cannabidiol multiple interactions ISO RGD:1320242 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of DLL4 protein] CTD PMID:30825431 choline multiple interactions ISO RGD:1320242 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DLL4 gene CTD PMID:20938992 deguelin decreases expression ISO RGD:1320241 6480464 deguelin results in decreased expression of DLL4 mRNA CTD PMID:33512557 diarsenic trioxide decreases expression ISO RGD:1320241 6480464 Arsenic Trioxide results in decreased expression of DLL4 CTD PMID:25088040 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of DLL4 mRNA, Dibutyl Phthalate results in increased expression of DLL4 protein CTD PMID:29438945 dioxygen multiple interactions ISO RGD:1320242 6480464 cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Oxygen results in increased expression of DLL4 mRNA] CTD PMID:25203536 dioxygen increases expression ISO RGD:1320241 6480464 Oxygen deficiency results in increased expression of DLL4 mRNA CTD PMID:26516004 dioxygen increases expression ISO RGD:1320242 6480464 Oxygen results in increased expression of DLL4 mRNA CTD PMID:25203536 epoxiconazole decreases expression ISO RGD:1320242 6480464 epoxiconazole results in decreased expression of DLL4 mRNA CTD PMID:35436446 folic acid multiple interactions ISO RGD:1320242 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DLL4 gene CTD PMID:20938992 folic acid increases expression ISO RGD:1320242 6480464 Folic Acid results in increased expression of DLL4 mRNA CTD PMID:25629700 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of DLL4 mRNA CTD PMID:33387578 hydrogen cyanide decreases expression ISO RGD:1320242 6480464 Hydrogen Cyanide results in decreased expression of DLL4 mRNA CTD PMID:33914522 L-methionine multiple interactions ISO RGD:1320242 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DLL4 gene CTD PMID:20938992 leflunomide increases expression ISO RGD:1320241 6480464 leflunomide results in increased expression of DLL4 mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:1320241 6480464 licochalcone B results in increased expression of DLL4 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO RGD:1320241 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1320241 6480464 Lipopolysaccharides results in increased expression of DLL4 mRNA CTD PMID:35811015 manganese(II) chloride increases expression ISO RGD:1320242 6480464 manganese chloride results in increased expression of DLL4 mRNA CTD PMID:17467022 methapyrilene increases methylation ISO RGD:1320241 6480464 Methapyrilene results in increased methylation of DLL4 3' UTR CTD PMID:30157460 methotrexate affects expression ISO RGD:1320242 6480464 Methotrexate affects the expression of DLL4 mRNA CTD PMID:18502557 methylisothiazolinone increases expression ISO RGD:1320241 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of DLL4 mRNA CTD PMID:31629900 octadecanoic acid increases expression ISO RGD:1320241 6480464 stearic acid results in increased expression of DLL4 mRNA CTD PMID:32347412 ozone multiple interactions ISO RGD:1320242 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DLL4 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DLL4 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:1320242 6480464 Acetaminophen affects the expression of DLL4 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DLL4 mRNA CTD PMID:33387578 picoxystrobin decreases expression ISO RGD:1320241 6480464 picoxystrobin results in decreased expression of DLL4 mRNA CTD PMID:33512557 potassium chromate multiple interactions ISO RGD:1320241 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of DLL4 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1320241 6480464 potassium chromate(VI) results in increased expression of DLL4 mRNA CTD PMID:22079256 potassium cyanide decreases expression ISO RGD:1320242 6480464 Potassium Cyanide results in decreased expression of DLL4 mRNA CTD PMID:33914522 propranolol multiple interactions ISO RGD:1320241 6480464 DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP2 protein], DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP9 protein] CTD PMID:30130526 propranolol decreases expression ISO RGD:1320241 6480464 Propranolol results in decreased expression of DLL4 protein CTD PMID:30130526 prostaglandin F2alpha decreases expression EXP 6480464 Dinoprost results in decreased expression of DLL4 mRNA CTD PMID:21209419 pyrimidifen decreases expression ISO RGD:1320241 6480464 pyrimidifen results in decreased expression of DLL4 mRNA CTD PMID:33512557 resveratrol multiple interactions ISO RGD:1320241 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of DLL4 mRNA CTD PMID:23557933 rotenone decreases expression ISO RGD:1320241 6480464 Rotenone results in decreased expression of DLL4 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1320241 6480464 [S-(1 more ... CTD PMID:35811015 silicon dioxide increases expression ISO RGD:1320241 6480464 Silicon Dioxide analog results in increased expression of DLL4 mRNA CTD PMID:23806026 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of DLL4 mRNA CTD PMID:19109527 Soman decreases expression EXP 6480464 Soman results in decreased expression of DLL4 mRNA CTD PMID:19281266 Soman increases expression EXP 6480464 Soman results in increased expression of DLL4 mRNA CTD PMID:19281266 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of DLL4 mRNA CTD PMID:31150632 titanium dioxide decreases expression ISO RGD:1320242 6480464 titanium dioxide results in decreased expression of DLL4 mRNA CTD PMID:23557971 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of DLL4 mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:1320242 6480464 trimellitic anhydride results in increased expression of DLL4 mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:1320242 6480464 triptonide results in increased expression of DLL4 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1320242 6480464 troglitazone results in increased expression of DLL4 mRNA CTD PMID:17569031 urethane increases expression ISO RGD:1320241 6480464 Urethane results in increased expression of DLL4 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1320242 6480464 Valproic Acid affects the expression of DLL4 mRNA CTD PMID:17292431 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of DLL4 mRNA CTD PMID:23034163 zinc atom multiple interactions ISO RGD:1320242 6480464 [zinc chloride results in increased abundance of Zinc] which results in decreased expression of DLL4 mRNA CTD PMID:31588059 zinc dichloride multiple interactions ISO RGD:1320242 6480464 [zinc chloride results in increased abundance of Zinc] which results in decreased expression of DLL4 mRNA CTD PMID:31588059 zinc(0) multiple interactions ISO RGD:1320242 6480464 [zinc chloride results in increased abundance of Zinc] which results in decreased expression of DLL4 mRNA CTD PMID:31588059
